TransEnterix is currently developing a patient-side robotic system called the SurgiBot™ System. The system is designed to be controlled directly by the surgeon, with enhanced vision and robotic motion. SurgiBot System design incorporates deployment of flexible instruments and a high-definition 3D articulating scope through a single incision.
The SurgiBot System is currently in development and has not yet been cleared by the FDA for sale in the United States or by other regulatory authorities for sale outside the United States.
September 21, 2015
TransEnterix Acquires the ALF-X Surgical Robotic System
August 31, 2015
TransEnterix, Inc. Names Paul Ziegler as Vice President of Sales
June 15, 2015
Triangle Business Journal: RTP’s TransEnterix raises $50M for commercial launch of surgery robot
June 02, 2015
Triangle Business Journal: Research Triangle Park’s TransEnterix takes big step with surgical robot